These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


276 related items for PubMed ID: 8732106

  • 1. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S, Yao K, Cao Y.
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [Abstract] [Full Text] [Related]

  • 2. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y, Luo B, Zhao P, Huang BH.
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [Abstract] [Full Text] [Related]

  • 3. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 4. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ.
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [Abstract] [Full Text] [Related]

  • 5. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
    Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N.
    N Engl J Med; 1995 Sep 14; 333(11):693-8. PubMed ID: 7637746
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q, Sato H, Murono S, Furukawa M, Yoshizaki T.
    Laryngoscope; 2004 May 14; 114(5):855-9. PubMed ID: 15126743
    [Abstract] [Full Text] [Related]

  • 7. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K.
    J Med Virol; 2003 Jul 14; 70(3):410-9. PubMed ID: 12767005
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT, Fernandes BJ, Mock D.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 14; 92(2):184-93. PubMed ID: 11505266
    [Abstract] [Full Text] [Related]

  • 9. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
    Chang MH, Ng CK, Lin YJ, Liang CL, Chung PJ, ChenML, Tyan YS, Hsu CY, Shu CH, Chang YS.
    DNA Cell Biol; 1997 Jul 14; 16(7):829-37. PubMed ID: 9260926
    [Abstract] [Full Text] [Related]

  • 10. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
    Burgos JS, Vera-Sempere FJ.
    Anticancer Res; 2001 Jul 14; 21(6A):3921-4. PubMed ID: 11911270
    [Abstract] [Full Text] [Related]

  • 11. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
    Sun N, Chen X.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995 Jul 14; 30(4):213-5. PubMed ID: 8745459
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.
    Ai Zheng; 2006 Feb 14; 25(2):136-42. PubMed ID: 16480574
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Raab-Traub N.
    Infect Agents Dis; 1992 Aug 14; 1(4):173-84. PubMed ID: 1365543
    [Abstract] [Full Text] [Related]

  • 14. [Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].
    Chen XY, Ning S, Arrand JR.
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug 14; 23(4):200-3. PubMed ID: 7805145
    [Abstract] [Full Text] [Related]

  • 15. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
    Yoshizaki T, Horikawa T, Qing-Chun R, Wakisaka N, Takeshita H, Sheen TS, Lee SY, Sato H, Furukawa M.
    Clin Cancer Res; 2001 Jul 14; 7(7):1946-51. PubMed ID: 11448908
    [Abstract] [Full Text] [Related]

  • 16. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT, Lin CR, Tan GK, Chen W, Dee AN, Chan WY.
    Am J Pathol; 1997 May 14; 150(5):1745-56. PubMed ID: 9137098
    [Abstract] [Full Text] [Related]

  • 17. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.
    Hao SP, Tsang NM, Chang KP.
    Cancer; 2003 Apr 15; 97(8):1909-13. PubMed ID: 12673717
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G, Agathanggelou A, Nicholls JM.
    Semin Cancer Biol; 1996 Aug 15; 7(4):165-74. PubMed ID: 8946600
    [Abstract] [Full Text] [Related]

  • 19. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D, Srivatanakul P, Karalak A, Ishida T.
    J Clin Virol; 2008 May 15; 42(1):1-6. PubMed ID: 18180201
    [Abstract] [Full Text] [Related]

  • 20. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X, Liu X, Li CY, Ding Y, Chau D, Li G, Kung HF, Lin MC, Peng Y.
    Int J Oncol; 2006 Sep 15; 29(3):595-603. PubMed ID: 16865275
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.